- Name: KINERET
- Generic Name: Anakinra
- Strength: 100 mg/0.67 mL solution for Subcutaneous Injection
- Manufactured: Swedish Orphan Biovitrum AB
Kineret (Anakinra 100 mg / 0.67 mL solution) is an interleukin-1 receptor antagonist used for:
Rheumatoid Arthritis (RA): Reduction in signs and symptoms and resisting the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients aged 18 years or older who have failed single/multiple disease modifying antirheumatic drugs (DMARDs).
Cryopyrin-Associated Periodic Syndromes (CAPS): Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
Kineret (Anakinra) is an FDA approved drug.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.